Vuse Go 700: Zero-Nicotine Vaping Products Now Available in Japan

VUSE by 2FIRSTS.ai
Dec.08.2023
Vuse Go 700: Zero-Nicotine Vaping Products Now Available in Japan
British American Tobacco Japan has launched its zero nicotine vapor product, "Vuse Go 700", in convenience stores in Tokyo.

According to a report by Japanese media outlet Cnet on December 8, British American Tobacco Japan has expanded the distribution of its zero-nicotine vapor product, "Vuse Go 700," to convenience stores. Starting from December 18, the product will be sold at FamilyMart, a convenience store chain with 2,300 locations in Tokyo.

Vuse Go 700: Zero-Nicotine Vaping Products Now Available in Japan
Image Source: Asahi Shimbun

 

In April this year, the Japanese BAT launched four limited edition, nicotine-free products, with approximately 10,000 units sold out within two months. The overwhelming approval of about 90% of users prompted them to begin a full-scale expansion in August this year.

 

The latest edition of Vuse Go 700 maintains the manufacturer's suggested retail price of 980 yen.

 

Vuse Go 700 is available in four out of the eight available options at FamilyMart convenience stores. These options include "Vuse Go 700 Mint Ice," "Vuse Go 700 Blueberry Ice," "Vuse Go 700 Classic Regular," and "Vuse Go 700 Mango Ice." The main vapor flavors consist of mint, fruit, and regular flavors, offering a variety to meet various taste preferences.

 

According to reports, in November 2023, the Vuse Go 700 will be offered for a limited time at the country's largest vaporizer specialty store, "Vape Studio.

 

Notice

1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.

2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.

3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.

Copyright

This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.

This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.